Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to CMC-and-Product-Quality

CMC & Product Quality

Innovation in CMC (Chemistry, Manufacturing and Controls) is at the heart of the pharmaceutical industry. Advances in regulatory practice and novel approaches to supply are key to this topic. This track will provide insights into how manufacturers and regulators can collaborate to deliver this revolution without risks to the supply of medicines.

Who is This Track Designed For?

This track is recommended for regulatory affairs, manufacturing, supply chain, quality assurance, and other professionals who want to keep up to date with the most recent developments in regulatory science and technology impacting CMC/GMP related activities.

Topic Leader

Mark Pellett

Mark Pellett

Senior Director and Group Manager

AstraZeneca, United Kingdom

Sarah Miksinski

Sarah Miksinski

Executive Director, CMC Regulatory Affairs

Gilead Sciences

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.